Clear cell renal cell carcinoma (ccRCC) is the most frequent histological kidney cancer
subtype. Over the last decade, significant progress has been made in identifying the genetic …

KIM-1 (kidney injury molecule 1) is a transmembrane glycoprotein also known as HAVcr-1
and TIM-1 belongs to the T-cell immunoglobulin and mucin domain family (TIM) of proteins …

Cisplatin is an effective chemotherapeutic agent, but significant nephrotoxicity limits its
clinical use. Despite extensive investigation of the acute cellular and molecular responses to …

Clear cell ovarian carcinoma (CCOC) and endometrioid ovarian carcinoma (ENOC) are
ovarian carcinoma histotypes, which are both thought to arise from ectopic endometrial (or …

BACKGROUND: The aim of this study is to summarize and quantify the current evidence on
the therapeutic efficacy of laparoscopic radical nephrectomy (LRN) compared with open …

Background Cancer cachexia is associated with patient outcomes. Objective The objective
was to evaluate the effect of cachexia on survival among patients with metastatic renal cell …

Objectives To review urinary protein biomarkers as potential non‐invasive, easily
obtainable, early diagnostic tools in renal cell carcinoma (RCC). Methods A PubMed …

Renal cell carcinoma is the most common form of the kidney cancer accounting for more
than 85% of the cases of which clear cell renal cell carcinoma (ccRCC) is the major …

Metastatic renal cell carcinoma (RCC) is a tumor entity with poor prognosis due to limited
therapy options. Tyrosine kinase inhibitors (TKI) represent the standard of care for RCCs …

Objective High expression of phosphorylated signal transducer and activator of transcription
3 (p-STAT3) has been detected in a variety of human tumors. However, the association of …